For patients with COPD, inhaled medications are a critically important part of their care. For medical professionals however it’s nearly impossible to assess how a patient is using these medications based on self-reporting. This is the dilemma that Cleveland Clinic researchers attempted to address in a study of the effects of an electronic monitoring platform developed by Propeller Health.
COPD patients who had at least one hospitalisation in the year prior to the study took part, and were provided with electronic monitoring devices on their inhalers. The device senses when the medication is used, and transmits this data to the patient’s smartphone, which in turn delivers alerts and insights on usage trends. This information was also emailed to the study team.
Over the year the study was conducted, the average trips to hospital of the group fell from 3.4 to 2.2, a significant benefit for such a common condition. The full results of the study were published in the Journal of Telemedicine and Telecare.
>> Read the full article here